BiotechTube

Aceclidine+tropicamide combination + Aceclidine + Vehicle

Phase 2Completed
0 watching 0 views this week⚡ Active
44
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Presbyopia

Conditions

Presbyopia

Trial Timeline

Apr 30, 2017 → May 20, 2018

NCT ID
NCT03201562

About Aceclidine+tropicamide combination + Aceclidine + Vehicle

Aceclidine+tropicamide combination + Aceclidine + Vehicle is a phase 2 stage product being developed by LENZ Therapeutics for Presbyopia. The current trial status is completed. This product is registered under clinical trial identifier NCT03201562. Target conditions include Presbyopia.

Hype Score Breakdown

Clinical
17
Activity
12
Company
2
Novelty
5
Community
5

Clinical Trials (1)

NCT IDPhaseStatus
NCT03201562Phase 2Completed

Competing Products

14 competing products in Presbyopia

See all competitors
ProductCompanyStageHype Score
AGN-241622 + VehicleAbbViePhase 1/2
41
AGN-190584AbbVieApproved
85
AGN-190584 + VehicleAbbViePhase 3
77
UNR844 + PlaceboNovartisPhase 2
52
UNR844-Cl + PlaceboNovartisPhase 2
52
Pilocarpine Ophthalmic Topical Cream, Dose 1 + Pilocarpine Ophthalmic Topical Cream, Dose 2 + Pilocarpine Ophthalmic Topical Cream, Dose 3 + Placebo Ophthalmic Topical CreamGlaukosPhase 2
49
Aceclidine+Brimonidine combination ophthalmic solution + Aceclidine ophthalmic solution + Placebo (Vehicle) ophthalmic solutionLENZ TherapeuticsPhase 3
69
Aceclidine+Brimonidine combination ophthalmic solution + Aceclidine ophthalmic solution + Vehicle Proprietary Ophthalmic SolutionLENZ TherapeuticsPhase 2
44
Aceclidine+Brimonidine combination ophthalmic solution + Placebo + Aceclidine Ophthalmic SolutionLENZ TherapeuticsPhase 3
69
PRX-100 + PlaceboLENZ TherapeuticsPhase 2
44
LNZ101 (Aceclidine /Brimonidine) ophthalmic solution + LNZ100 (Aceclidine) ophthalmic solution + Placebo (Vehicle) ophthalmic solutionLENZ TherapeuticsPhase 1
25
Aceclidine+Brimonidine combination ophthalmic solution + Aceclidine ophthalmic solution + VehicleLENZ TherapeuticsPhase 3
69
Aceclidine+Brimonidine combination ophthalmic solution + Aceclidine ophthalmic solution + Vehicle proprietary ophthalmic solutionLENZ TherapeuticsPhase 2
44
Aceclidine+Brimonidine combination ophthalmic solution + Aceclidine ophthalmic solution + BrimonidineLENZ TherapeuticsPhase 3
69

Other Products from LENZ Therapeutics

Aceclidine+Brimonidine combination ophthalmic solution + Aceclidine ophthalmic solution + Placebo (Vehicle) ophthalmic solutionPhase 3
69
Aceclidine+Brimonidine combination ophthalmic solution + Placebo + Aceclidine Ophthalmic SolutionPhase 3
69
Aceclidine+Brimonidine combination ophthalmic solution + Aceclidine ophthalmic solution + VehiclePhase 3
69
Aceclidine+Brimonidine combination ophthalmic solution + Aceclidine ophthalmic solution + BrimonidinePhase 3
69
Aceclidine+Brimonidine combination ophthalmic solution + Aceclidine ophthalmic solution + Vehicle Proprietary Ophthalmic SolutionPhase 2
44